Last reviewed: June 19, 2026
Last updated: June 19, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Ozempic (semaglutide) is a GLP-1 receptor agonist originally developed for type 2 diabetes that has demonstrated significant weight reduction effects in clinical trials. The medication works through a structured dosing protocol that allows your body to adjust gradually while maximizing efficacy and tolerability. Understanding how semaglutide dosing progresses helps patients and providers make informed treatment decisions.
How Semaglutide Dosing Starts and Progresses
Semaglutide weight loss treatment begins with a low starting dose to minimize gastrointestinal side effects and allow metabolic adjustment. The standard initiation protocol uses 0.25 mg injected subcutaneously once weekly for the first month. This introductory phase establishes tolerance while your body begins responding to GLP-1 pathway activation.
After the initial four-week period, the dose increases to 0.5 mg weekly in month two. Each subsequent month typically adds another 0.25 mg increment until reaching 2.4 mg weekly, which represents the therapeutic dose most commonly used in weight management studies. This titration ladder usually requires 12 weeks total to reach full therapeutic dosing, though individual timelines vary based on tolerance and clinical response.
Standard Maintenance Dosage and Treatment Duration
The maintenance dose for semaglutide weight loss therapy is typically 2.4 mg administered as a single subcutaneous injection once per week. This dosage was selected based on clinical evidence showing optimal balance between weight reduction outcomes and side effect tolerability in large population studies. Most patients continue at this level as long as treatment benefits outweigh any adverse effects.
Treatment duration varies widely depending on individual goals, response patterns, and ongoing clinical monitoring. Some patients maintain semaglutide for 12 to 24 months, while others continue longer-term as part of comprehensive weight management plans. Your dosing timeline and maintenance level should be determined collaboratively between you and your prescribing provider based on your unique health profile and response metrics.
Factors That Influence Your Semaglutide Dosing Plan
Kidney function, liver health, and gastrointestinal tolerance directly impact how quickly your dose can increase and what maintenance level works best. Patients with certain medical conditions may require slower titration schedules or lower maximum doses to ensure safety. Your healthcare provider will assess these factors during initial evaluation and ongoing follow-up visits.
Genetic variations in peptide-response pathways can influence how your body metabolizes and responds to semaglutide therapy. PlexusDx offers the Precision Peptide Genetic Test, which analyzes 14 metabolic pathways including GLP1R rs6923761 and GIPR rs1800437 variants to help predict your individual responsiveness. This genetic insight enables more personalized dosing recommendations aligned with your biological predispositions toward weight reduction.
Cost and Access for Semaglutide at PlexusDx
PlexusDx compounded semaglutide injections start at $149 per month with flat pricing across all dose levels—meaning your monthly cost remains the same whether you're taking 0.25 mg or 2.4 mg. This transparent pricing structure removes financial barriers to dose optimization and eliminates unexpected cost increases as your treatment progresses. No insurance is required, no membership fees apply, and HSA and FSA accounts are accepted.
All PlexusDx medications come from licensed 503A compounding pharmacies and are available to patients across all 50 states. After your first month of treatment, the optional Precision Peptide Genetic Test is available for $99 as an add-on to further personalize your protocol. PlexusDx coordinates with your provider to ensure dosing adjustments align with your clinical progress and genetic insights.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the typical starting dose of semaglutide for weight loss?
The standard starting dose is 0.25 mg injected once weekly for the first four weeks. This low-dose initiation minimizes nausea and gastrointestinal upset while your body adjusts to GLP-1 activation. PlexusDx provides compounded semaglutide injections following this evidence-based titration schedule.
How long does it take to reach the full therapeutic dose?
Most patients reach the maintenance dose of 2.4 mg within 12 weeks using the standard escalation protocol, which increases by 0.25 mg every four weeks. Some individuals titrate more slowly based on tolerance, which may extend the timeline by several additional weeks. Your provider will adjust pace based on your response and side effect profile.
Will my PlexusDx cost increase if my semaglutide dose goes up?
No. PlexusDx compounded semaglutide injections maintain flat pricing at $149 per month regardless of your dose level. Your dose may need to go up, but your price won't—this transparent model eliminates surprise costs during treatment optimization.
What if I experience side effects at my current dose?
Dose reduction or slower titration is appropriate if gastrointestinal symptoms become intolerable. Nausea typically improves with time, dietary adjustments, and slower dose escalation. Your PlexusDx provider can modify your protocol and monitor your adjustment carefully to balance efficacy with comfort.
How does the Precision Peptide Genetic Test help with my dosing?
The PlexusDx genetic test examines variants like GLP1R rs6923761 and GIPR rs1800437 across 14 metabolic pathways to predict your individual responsiveness to semaglutide. This insight helps your provider anticipate whether you might benefit from standard dosing or require personalized adjustments, available for $99 after your first month of treatment.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Setting Expectations: How Soon Will Wegovy Start Working for You?
Navigating Your Journey: What Foods to Be Mindful of While Taking Ozempic